Abstract. Since resveratrol (3,4',5 tri-hydroxystilbene), which has been shown to inhibit multistage carcinogenesis, is not a potent cytotoxic compound, several studies were undertaken to obtain synthetic analogues of resveratrol with potent activity. We previously reported that a resveratrol derivative HS-1793 exhibits stronger antitumor effects than resveratrol in several cancer cell types. The present study was undertaken to reveal precise mechanism by which HS-1793 induces cell death. The induction of CCAAT/enhancerbinding protein-homologous protein (CHOP) and glucoseregulated protein (GRP)-78, and ER stress-specific XBP1 splicing were found in HT29 human colon carcinoma cells treated with resveratrol. Conversely, these manifestations were not observed in HT29 cells treated with HS-1793. Inhibition of caspase-4 activity by z-LEVD-fmk significantly reduced the induction of apoptosis by resveratrol but not by HS-1793. These findings suggest that HS-1793, contrary to resveratrol, does not induce ER stress-mediated apoptosis. Importantly, we observed that HS-1793 but not resveratrol decreased phosphorylated Akt level. We also demonstrated that HS-1793, compared to resveratrol, exerted more effective apoptosis inducing activity in Akt-activated cells. Taken together, the stronger antitumor activity of HS-1793 originates, at least in part, from its ability for Akt inactivation.
Introduction
Resveratrol (3,4',5 tri-hydroxystilbene) is a phytochemical known to be partly responsible for the cardioprotective effects of red wine due to a variety of its biological activities (1, 2) . Resveratrol has been shown to exert chemopreventive effects against cancer based on its inhibition of cellular events associated with tumor initiation, promotion and progression in a variety of cell culture systems and animal models (3) . Resveratrol is also able to activate mitochondria or ER stress-mediated apoptosis and non-apoptotic cell death (autophagocytosis) (4) (5) (6) .
The endoplasmic reticulum (ER) is an organelle responsible for protein synthesis and modification, and storage of calcium (7, 8) . ER dysfunction results in a stressful condition, called ER stress. The key players of the unfolded protein response (UPR) are three chronologically-activated ER resident-signaling proteins: protein kinase-like ER-resident kinase (PERK), inositol requiring 1 (Ire1) and activating transcription factor-6 (ATF-6) (9-12). Prolonged or severe ER stress is widely considered to trigger apoptosis. Several pro-apoptotic factors and signaling pathways, including CCAAT/enhancer-binding protein-homologous protein (CHOP), pro-apoptotic Bcl-2 family members, caspase-12 and c-Jun N-terminal kinase (JNK) have been shown to be involved in ER stress-induced cell death (13) (14) (15) (16) .
However, the concentration of resveratrol required to exert chemopreventive effects (40-200 μM) is relatively high (17) . Therefore, developing more potent derivative of resveratrol may provide a feasible means of achieving an effective physiologic concentration. Recently, we reported that a novel resveratrol derivative, HS-1793, is more potent than resveratrol and overcomes the resistance conferred by Bcl-2 (18) . However, the precise mechanism by which HS-1793 induces cell death is not fully understood. The aim of this study was to determine the capacity of HS-1793 to induce apoptosis and identify the biochemical mechanisms of this induction as well as novel target(s) including Akt signaling pathways in a cancer cells. The present study was Western blotting. Cellular lysates were prepared by suspending 1x10 6 cells in 100 μl of lysis buffer (137 mM NaCl, 15 mM EGTA, 0.1 mM sodium orthovanadate, 15 mM MgCl 2 , 0.1% Triton X-100, 25 mM MOPS, 100 μM phenylmethylsulfonylfluoride and 20 μM leupeptin, adjusted to pH 7.2). The cells were disrupted by sonication and extracted at 4˚C for 30 min. The proteins were electrotransferred to immobilon-P membranes (Millipore Corporation, Bedford, MA, USA). Detection of specific proteins was carried out with an ECL Western blotting kit according to the manufacturer's instructions.
Cell count and flow cytometry analysis. Cell counts were performed using a hemocytometer. Approximately 1x10 6 HT29 cells were suspended in 100 μl of PBS and 200 μl of 95% ethanol were added while vortexing. The cells were incubated at 4˚C for 1 h, washed with PBS and resuspended in 250 μl of 1.12% sodium citrate buffer (pH 8.4) together with 12.5 μg of RNase. Incubation was continued at 37˚C for 30 min. The cellular DNA was then stained by applying 250 μl of propidium iodide 50 μg/ml) for 30 min at room temperature. The stained cells were analyzed by fluorescentactivated cell sorting (FACS) on a FACScan flow cytometer for relative DNA content based on red fluorescence.
RNA isolation and reverse transcriptase-polymerase chain reaction (RT-PCR).
Total cellular RNA was extracted from cells using the TRIzol reagent (Life Technologies). A cDNA was synthesized from 2 μg of total RNA using M-MLV reverse transcriptase (Gibco-BRL, Gaithersburg, MD). The cDNA for XBP1 was amplified by PCR with specific primers: XBP1 (sense) 5'-CCTTGTAGTTGAGAACCAGG-3' and (anti-sense) 5'-GGGGCTTGGTATATATGTGG-3'. PCR amplification was carried out as follows: 1X (94˚C, 3 min); 30X (94˚C, 45 sec; 57˚C, 45 sec; and 72˚C, 1 min); and 1X (72˚C, 10 min). PCR products were analyzed by agarose gel electrophoresis and visualized by ethidium bromide.
Expression of constitutively active Akt. Akt-overexpressing U937 cells were generated using a Myc-His-tagged mouse Aktl (activated) under the control of the cytomegalovirus promoter (Upstate Biotechnology), respectively. U937 cells (2x10 6 cells/ml) in RPMI-1640 medium were transfected by preincubation with 15 μg Akt plasmid for 10 min at room temperature followed by electroporation at 500 V, 700 μF. The sample was immediately placed on ice for 10 min, and after 10 ml complete medium was added, the cells were incubated at 37˚C for 24 h. The cells were selected in a medium containing 0.7 μg/ml geneticin (G418 sulfate) for 4 weeks. Single cell clones were obtained by limiting dilution and subsequently analyzed for an increase in Akt protein expression relative to the identically cloned empty vector control.
Preparation of nuclear extract. After required treatment, HT29 cells were trypsinized and suspended in low salt buffer (20 mM Tris at pH 4.0, 20 mM KCl, 1.5 mM MgCl 2 , 1 mM DTT, 25% glycerol, 0.2 mM EDTA, 10 μg/ml leupeptin and 5 μg/ml aprotinin). After incubation on ice for 30 min, the cells were then centrifuged at 2,500 rpm for 3 min to obtained nuclear pellet. The high salt buffer (20 mM Tris at pH 4.0, 1.2 M KCl, 1.5 mM MgCl 2 , 1 mM DTT, 25% glycerol, 0.2 mM EDTA, 10 μg/ml leupeptin and 5 μg/ml aprotinin) was added followed by rotating the nuclei for 30 min at 4˚C. The resulting lysates were then centrifuged at 12,000 rpm at 4˚C for 5 min. The supernatants were collected as nuclear extract.
Measurement of intracellular calcium concentration ([Ca 2+ ] i ). Microfluorescent imaging of intracellular calcium concentration ([Ca
] i ) was performed on cultured HT29 cells loaded with the calcium indicator dye fura-2/AM. Some of the procedures used in calcium imaging in this experiment have been described (19) . Fura-2/AM (3 μM) was added to HT29 cells bathed in 1.8 mM Ca 2+ containing physiological saline solution at room temperature for 30 min followed by a 30-min wash in dye-free saline solution to allow esterase conversion to free form of fura-2. Cover slips were placed on the stage of an inverted microscope and imaging was performed with a dual-wavelength system (Intracellular Imaging, Cincinnati, OH, USA). [Ca 2+ ] i was calculated as the relationship between the ratio of emissions at 510 nm from excitation at 340 and 380 nm, respectively. Ratio images were processed every 5 sec and converted to [Ca 2+ ] i as compared to a range of such ratios obtained by measurement of fura-2 in the presence of known concentration of calcium (Calcium Calibration Buffer Kit, Molecular Probe, Eugene, OR, USA). Each experimental data point represents the mean [Ca 2+ ] i calculated from at least 12 individually measured cells from three separate cultures. All imaging experiments were done at room temperature (20-22˚C).
Results

Cellular features characteristic of apoptosis in HT29 cells
exposed to resveratrol or HS-1793. HT29 (human colon carcinoma) cells were treated with various concentrations of resveratrol or HS-1793. Apoptosis was determined in HT29 cells using flow cytometry analysis demonstrating hypodiploid DNA. As shown in Fig. 1 , treatment with resveratrol or HS-1793 in HT29 cells resulted in a markedly increased accumulation of sub-G1 phase in a dose-dependent manner. These data indicated that HS-1793 is more potent than resveratrol. Because cells undergoing apoptosis execute the death program by activating caspases and cleavage of PARP, we analyzed expression levels of pro-caspase-3 and cleavage of PARP. As shown in Fig. 1 , exposure to both resveratrol and HS-1793 led to a reduction of the 32-kDa precursor, accompanied by cleavage of PARP. Activation of ATF6 and the subsequent induction of GRP78 and CHOP are known to be one of the hallmarks of the ER stress responses (8) . Thus, we examined the effect of resveratrol or HS-1793 on the expression of GRP78 and CHOP by Western blotting. As shown in Fig. 1 , treatment with resveratrol induced the expression of GRP78 and CHOP protein in a dose-dependent manner but not with HS-1793.
HS-1793 does not induce splicing of XBP1 mRNA.
During ER stress, the mRNA encoding the transcription factor XBP1 is spliced by the endoribonuclease IRE1 that results in the removal of 26-nucleotide intron and a translational frame shift (12, 20) . The spliced XBP1 mRNA is translated into a functional transcriptional activator (12, 20) . Thus, we examine the alternative splicing of XBP1 mRNA using RT-PCR and Western blotting. As shown in Fig. 2 , resveratrol induced the splicing of XBP1 mRNA and expression of spliced XBP1 protein. However, HS-1793 did not induce splicing of XBP1 mRNA and expression of spliced XBP1 protein.
Role of caspase-4 in resveratrol-induced apoptosis of HT-29 cells.
To corroborate that apoptosis induced by HS-1793 is not ER stress-mediated, we examined the effect of a pancaspase inhibitor z-VAD-fmk and a caspase-4-specific inhibitor z-LEVD-fmk. Induction of apoptosis by resveratrol was significantly reduced not only z-VAD-fmk but also by z-LEVD-fmk as determined by DNA hypoploidy (Fig. 3A) . In addition, both z-LEVD-fmk and z-VAD-fmk prevented cleavage of PARP in HT-29 cells treated with resveratrol (Fig. 3A) . However, HS-1793-induced apoptosis was inhibited by z-VAD-fmk, but not z-LEVD-fmk. Taken together, our results suggest that resveratrol-induced apoptosis is associated with its ability to cause ER stress, but not HS-1793.
Resveratrol induces depletion of intracellular Ca
2+ stores. There is abundant evidence that dysregulation of Ca 2+ homeostasis is critically involved in ER stress-mediated apoptosis (7, 8) . Thus, we next tested the effect of resveratrol or HS-1793 on cytosolic calcium in HT29 cells. As shown in Fig. 4 
HS-1793 induces down-regulation of Akt phosphorylation.
Although we undertook the present study to dissect the mechanism underlying the potent apoptosis inducing activity of HS-1793, the above results suggest that whereas resveratrol induces, at least in part, apoptosis on HT-29 cells in ER stress-mediated pathway, apoptosis inducing activity of HS-1793 is not associated with its ability to cause ER stress. Thus, we next focused the activity of HS-1793 on Akt activation. Since protein kinase B (PKB/Akt) is a serine/threonine kinase that has been established as an important intracellular signaling in regulating cell survival (21) . As shown in Fig. 5A , HT-29 cells treated with HS-1793 have no effect on steady state levels of total Akt protein, whereas phosphorylated Akt levels were decreased significantly in a time-dependent manner whereas resveratrol did not alter the level of phos- phorylated Akt. To further evaluate the modulation of Akt signaling by HS-1793, we employed U937/vector and U937/ DA-Akt cells generated by transfection of the constitutively active Myc-tagged form of Akt (myr-Akt). U937/vector and U937/myr-Akt cells were exposed to HS-1793 or resveratrol for 20 h. HS-1793 treatment in U937/vector cells resulted in a markedly increased accumulation of sub-G1 phase. In contrast, expression of constitutively active Akt reduced HS-1793-induced accumulation of sub-G1 phase (Fig. 5B) . HS-1793, compared to resveratrol, more effectively induced apoptosis in Akt-activated cells. We next analyzed the expression levels of phosphor-Akt, Akt and PARP cleavage in U937/vector and U937/myr-Akt cells exposed to HS-1793 or resveratrol. As shown in Fig. 5C , cleavage of PARP was prevented by ectopic expression of constitutively active Akt. Taken together, these results indicate that HS-1793 induces apoptosis via modulating the Akt signaling pathway.
The effect of HS-1793 or resveratrol on normal cell growth.
To this end, we investigated whether HS-1793 or resveratrol affects the induction of apoptosis in normal human skin fibroblast (HSF) cells. The apoptotic characteristics, such as cell shrinkage, apoptotic bodies and detachment from the plate, were frequently observed in Caki cells treated with HS-1793 or resveratrol (Fig. 6) . However, HSF cells were resistant to HS-1793 or resveratrol. Furthermore, their morphological changes and viability were not significantly affected by HS-1793 or resveratrol, demonstrating that HS-1793 or resveratrol preferentially induced apoptosis in cancer cells, sparing normal cells. 
Discussion
Although the cancer chemopreventive agent, resveratrol, has been shown to induce apoptosis in a variety of human cancer cell lines (1, 2) , current research on the use of resveratrol as potential cancer chemoprevention agent is limited, since resveratrol is not a potent cytotoxic agent when compared with other chemotherapeutic drugs. In an attempt to determine whether chemical modification of the stilbene backbone of resveratrol may further enhance its biological activity, our previous studies showed that HS-1793, a novel resveratrol derivative, may be superior to natural resveratrol as a candidate for chemoprevention agent (18) . In addition, HS-1793 induces apoptosis and overcomes the resistance conferred by Bcl-2 in U937 cells through down-regulation of 14-3-3 (18) . The present study provides important evidence to support the HS-1793, contrary to resveratrol, it does not induce apoptosis via ER stress-mediated pathway. In addition, we found that HS-1793 was substantially more potent than resveratrol at down-regulation of Akt phosphorylation. Known ER stresses include calcium store depletion, inhibition of glycosylation, reduction of disulfide bonds and overexpression of mutant proteins (22) (23) (24) . The present study demonstrates that induction of ER stress-related proteins may be involved in resveratrol-induced apoptosis. 1) Resveratrol induces GRP78 and CHOP expression. CHOP is one of the highest inducible genes during ER stress (8) . 2) Resveratrol induces splicing of XBP1 mRNA. Under ER stress conditions, XBP1 mRNA is processed by unconventional splicing and translated into a functional transcription factor (12, 20) . 3) Inhibition of caspase-4 activity by z-LEVD-fmk significantly reduced resveratrol-induced apoptosis. 4) Resveratrol induces depletion of intracellular Ca 2+ stores. However, HS-1793 did not induce ER stress-mediated apoptosis. The fact that resveratrol, but not HS-1793, exhibits differential ER stress-induced apoptotic effect suggests that structure-related mechanisms may be crucial in ER stress. Resveratrol is unstable and its stilbene double bonds are readily oxidized. HS-1793 does not contain this unstable double bond.
Akt/PKB is a serine/threonine protein kinase that functions as a critical regulator of cell survival and proliferation (25) (26) (27) . We have shown that Akt is dephosphorylated after treatment with HS-1793, but not resveratrol. Ectopic expression of constitutively active Akt reduces HS-1793-induced apoptosis. These results suggest that HS-1793-induced apoptosis is associated with Akt inactivation. The ability of Akt to promote cell survival is based on its ability to phosphorylate on residues necessary for their inactivation of several proapoptotic proteins, including Bad, caspase-9, transcription factors of the forkhead family and IKK (28) (29) (30) .
The identification of the nature of these structures may help to resolve the ER stress-mediated apoptotic mechanisms induced by resveratrol in cancer cells. These data suggest that ER stress may be of importance for the cytotoxic activity of resveratrol. However, how resveratrol causes ER stress in cancer cells is not clear. Interestingly, HS-1793 did not induce ER stress-mediated apoptosis, but it caused down-regulation of Akt phosphorylation. In addition, other targets of HS-1793 particularly could be further investigated by microarray. Therefore, further study on the resveratrol derivative is required to delineate exactly its reactions inside the cells, to explain its biological effects.
